Skip to main content Start main content

Academic Staff

People
Prof. Chen Xu
PolyU Scholars Hub

Prof. Chen Xu

Assistant Professor

Research Overview

Dr. Chen’s research is mainly focused on the epidemiology, mechanism, and lifestyle intervention of cardiometabolic diseases, especially metabolic dysfunction-associated steatotic liver disease (MASLD).

Education and Academic Qualifications

  • Bachelor of Medicine, Sun Yat-sen University
  • Doctor of Medicine, Sun Yat-sen University

Research Interests

  • Metabolic diseases
  • Molecular nutrition
  • Epidemiology
  • Randomized controlled trial

Achievements

(* Corresponding author; # Co-first author) 

  1. Xue H#, Wang L#, Sun D, Wu Y, Yu C, Huang Y, Chan SO, Ling W, Lv J, Li L, Chen X *, Pang Y *, Yu C *. Associations of Alcohol Consumption and Genetic Predisposition to Hepatic Steatosis With Liver-Related Events: Results From Large Population-Based Cohort Studies. Gastroenterology. 2025 May 14:S0016-5085(25)00712-7.   
  2. Xue H, Wang L, Wu Y, Liu X, Jiang J, Chan SO, Chen X *, Ling W *, Yu C *. Association of moderate alcohol intake with the risks of cirrhosis and steatotic liver disease: Results from a large population-based cohort study. Clin Nutr. 2024 Dec;43(12):75-83. 
  3. Chen X#, Chen S#, Pang J#, Huang R, You Y, Zhang H, Xiao J, Xue H*, Ling W*. Hepatic steatosis aggravates atherosclerosis via small extracellular vesicle-mediated inhibition of cellular cholesterol efflux. J Hepatol. 2023 Sep 5; S0168-8278(23)05077-8. 
  4. Chen S#, Pang J#, Huang R#, You Y, Zhang H, Xue H*, Chen X*. Associations of Macronutrients Intake with MRI-Determined Hepatic Fat Content, Hepatic Fibro-inflammation, and NAFLD. J Clin Endocrinol Metab. 2023 Jun 8; dgad346. 
  5. Chen S, Pang J, Huang R, Xue H*, Chen X*. Association of MAFLD with end-stage kidney disease: a prospective study of 337,783 UK Biobank participants. Hepatol Int. 2023 Jun;17(3):595-605.  
  6. Zhang P, Chen K, He T, Guo H*, Chen X*. Coenzyme Q10 supplementation improves adipokine profile in dyslipidemic individuals: a randomized controlled trial. Nutr Metab (Lond). 2022 Mar 3;19(1):13. 
  7. Xue H#, Chen X#, Yu C, Deng Y, Zhang Y, Chen S, Chen X, Chen K, Yang Y*, Ling W*. Gut Microbially Produced Indole-3-Propionic Acid Inhibits Atherosclerosis by Promoting Reverse Cholesterol Transport and Its Deficiency Is Causally Related to Atherosclerotic Cardiovascular Disease. Circ Res. 2022 Aug 19;131(5):404-420. 
  8. Chen X, Chen S, Pang J, Tang Y, Ling W*. Are the different MAFLD subtypes based on the inclusion criteria correlated with all-cause mortality? J Hepatol. 2021 Jun 18:S0168-8278(21)00421-9. 
  9. Chen X, Sun X, Shen T, Chen Q, Chen S, Pang J, Mi J, Tang Y, You Y, Xu H, Ling W*. Lower adropin expression is associated with oxidative stress and severity of nonalcoholic fatty liver disease. Free Radic Biol Med. 2020 Nov 20; 160:191-198 
  10. Chen X#, Xue H#, Fang W, Chen K, Chen S, Yang W, Shen T, Chen X, Zhang P, Ling W*. Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity. Redox Biol. 2019 Feb; 21:101068. 

Your browser is not the latest version. If you continue to browse our website, Some pages may not function properly.

You are recommended to upgrade to a newer version or switch to a different browser. A list of the web browsers that we support can be found here